AAAAAA
Results: 51-75/82
Authors:
Blacher, J
Staessen, JA
Girerd, X
Gasowski, J
Thijs, L
Liu, LS
Wang, JG
Fagard, RH
Safar, ME
Citation: J. Blacher et al., Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients, ARCH IN MED, 160(8), 2000, pp. 1085-1089
Authors:
Wang, JG
Staessen, JA
Gong, LS
Liu, LS
Citation: Jg. Wang et al., Chinese trial on isolated systolic hypertension in the elderly, ARCH IN MED, 160(2), 2000, pp. 211-220
Authors:
Staessen, JA
Thijs, L
Fagard, R
Citation: Ja. Staessen et al., Epidemiology as guide to the clinical use of ambulatory blood pressure monitoring, HBK HYPERT, 20, 2000, pp. 152-165
Authors:
Thijs, L
Celis, H
Fagard, R
Staessen, JA
Citation: L. Thijs et al., Diagnostic thresholds for self-recorded blood pressure measurements, HBK HYPERT, 20, 2000, pp. 166-177
Authors:
Staessen, JA
Wang, JG
Citation: Ja. Staessen et Jg. Wang, Benefit of antihypertensive drug treatment in older patients with isolatedsystolic hypertension, EUR H J SUP, 1(P), 1999, pp. P3-P8
Treatment of isolated systolic hypertension in the elderly: further evidence from the SYST-EUR trial
Authors:
Fagard, RH
Staessen, JA
Citation: Rh. Fagard et Ja. Staessen, Treatment of isolated systolic hypertension in the elderly: further evidence from the SYST-EUR trial, EUR H J SUP, 1(M), 1999, pp. M2-M5
Authors:
Seux, ML
Forette, F
Staessen, JA
Thijs, L
Birkenhager, WH
Webster, J
Babarskiene, MR
Babeanu, S
Bossini, A
Gil-Extremera, B
Girerd, X
Laks, T
Lilov, E
Moisseyev, V
Tuomilehto, J
Vanhanen, H
Yodfat, Y
Fagard, R
Citation: Ml. Seux et al., Treatment of isolated systolic hypertension and dementia prevention in older patients - Results of the Systolic Hypertension in Europe Trial (SYST-EUR) vascular dementia project, EUR H J SUP, 1(M), 1999, pp. M6-M12
Authors:
Fagard, RH
Staessen, JA
Citation: Rh. Fagard et Ja. Staessen, Treatment of isolated systolic hypertension in the elderly: The Syst-Eur trial, CLIN EXP HY, 21(5-6), 1999, pp. 491-497
Authors:
Liu, LS
Wang, JG
Celis, H
Staessen, JA
Citation: Ls. Liu et al., Implications of the systolic hypertension in China trial, CLIN EXP HY, 21(5-6), 1999, pp. 499-505
Authors:
Staessen, JA
Forette, F
Thijs, L
Gasowski, J
Seux, ML
Citation: Ja. Staessen et al., Untitled - Reply, J HUM HYPER, 13(6), 1999, pp. 419-420
Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress
Authors:
Gasowski, J
Staessen, JA
Celis, H
Fagard, RH
Thijs, L
Birkenhager, WH
Bulpitt, CJ
Fletcher, AE
Arabidze, GG
de Leeuw, P
Dollery, CT
Duggan, J
Kawecka-Jaszcz, K
Leonetti, G
Nachev, C
Safar, M
Rodico, JL
Rosenfeld, J
Seux, ML
Tuomilehto, J
Webster, J
Yodfat, Y
Citation: J. Gasowski et al., Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress, J HUM HYPER, 13(2), 1999, pp. 135-145
Authors:
Staessen, JA
Wang, JG
Thijs, L
Fagard, R
Citation: Ja. Staessen et al., Overview of the outcome trials in older patients with isolated systolic hypertension, J HUM HYPER, 13(12), 1999, pp. 859-863
Authors:
Fagard, RH
Pardaens, K
Staessen, JA
Thijs, L
Driessens, E
Citation: Rh. Fagard et al., Power spectral analysis of heart rate variability by autoregressive modeling and fast Fourier transform: a comparative study, ST HEAL T, 60, 1999, pp. 107-118
Authors:
Staessen, JA
Citation: Ja. Staessen, Ambulatory blood pressure monitoring in clinical trials, NIEREN HOCH, 28(12), 1999, pp. 462-464
Authors:
Fagard, RH
Pardaens, K
Staessen, JA
Citation: Rh. Fagard et al., Influence of demographic, anthropometric and lifestyle characteristics on heart rate and its variability in the population, J HYPERTENS, 17(11), 1999, pp. 1589-1599
Authors:
Staessen, JA
Kuznetsova, T
Wang, JG
Emelianov, D
Vlietinck, R
Fagard, R
Citation: Ja. Staessen et al., M235T angiotensinogen gene polymorphism and cardiovascular renal risk, J HYPERTENS, 17(1), 1999, pp. 9-17
Authors:
Staessen, JA
Wang, JG
Birkenhager, WH
Fagard, R
Citation: Ja. Staessen et al., Treatment with beta-blockers for the primary prevention of the cardiovascular complications of hypertension, EUR HEART J, 20(1), 1999, pp. 11-24
Authors:
Staessen, JA
Thijs, L
Birkenhager, WH
Bulpitt, CJ
Fagard, R
Citation: Ja. Staessen et al., Update on the systolic hypertension in Europe (Syst-Eur) trial, HYPERTENSIO, 33(6), 1999, pp. 1476-1477
Authors:
O'Brien, E
Staessen, JA
Citation: E. O'Brien et Ja. Staessen, What is hypertension? Reply, LANCET, 354(9178), 1999, pp. 594-594
Authors:
O'Brien, E
Staessen, JA
Citation: E. O'Brien et Ja. Staessen, What is "hypertension"?, LANCET, 353(9164), 1999, pp. 1541-1543
Authors:
Staessen, JA
Roels, HA
Emelianov, D
Kuznetsova, T
Thijs, L
Vangronsveld, J
Fagard, R
Citation: Ja. Staessen et al., Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study, LANCET, 353(9159), 1999, pp. 1140-1144
Authors:
Forette, F
Staessen, JA
Thijs, L
Birkenhager, WH
Citation: F. Forette et al., Prevention of dementia: Syst-Eur trial - Reply, LANCET, 353(9148), 1999, pp. 236-237
Authors:
Staessen, JA
Thijs, L
Fagard, R
O'Brien, ET
Clement, D
de Leeuw, PW
Mancia, G
Nachev, C
Palatini, P
Parati, G
Tuomilehto, J
Webster, J
Citation: Ja. Staessen et al., Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension, J AM MED A, 282(6), 1999, pp. 539-546
Authors:
Tuomilehto, J
Staessen, JA
Birkenhager, WH
Citation: J. Tuomilehto et al., Calcium-channel blockade and hypertension - Reply, N ENG J MED, 341(5), 1999, pp. 373-373
Authors:
Tuomilehto, J
Rastenyte, D
Birkenhager, WH
Thijs, L
Antikainen, R
Bulpitt, CJ
Fletcher, AE
Forette, F
Goldhaber, A
Palatini, P
Sarti, C
Fagard, R
Staessen, JA
Arabidze, GG
Carrageta, M
Celis, H
Kocemba, J
Leonetti, G
Nachev, C
O'Brien, ET
Ritz, E
Rodicio, JL
Rosenfeld, J
Heyrman, J
Stibbe, G
Van den Haute, H
Yodfat, Y
De Cort, P
Hubner, GE
Citation: J. Tuomilehto et al., Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension, N ENG J MED, 340(9), 1999, pp. 677-684